Vaccine approaches and immunological aspects of SARS-CoV-2 with Professor Katie Flanagan
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
In episode 8 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford, speaks with Professor Katie Flanagan. Katie is Head of Infectious Diseases at Launceston...
show more•Immunological aspects of SARS-CoV-2
•Vaccine responses in adults versus children and the difference in adult immune systems
•Vaccinology strategies being used in the development of a SARS-CoV-2 vaccine
•Antibody response variation by age
•Viral vector vaccines and how they work
•Novel vaccine approaches and the implications of these on vaccine safety including: mRNA and DNA SARS-CoV-2 vaccines
Links:
VACSIG: Vaccination Special Interest Group
https://www.asid.net.au/groups/vacsig
The Lancet: Immunogenicity and safety of recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults ages 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31605-6/fulltext
The Lancet: Safety and immunogenicity of the ChAdOx1 nCOV-19 vaccine against SARS-CoV-2: a preliminary report of a phase ½, single-blind, randomised controlled trial
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext
WHO draft landscape of COVID-19 candidate vaccines:
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
COVID-19 Vaccine tracker
https://www.covid-19vaccinetracker.org/
Information
Author | MVEC |
Organization | MVEC |
Website | - |
Tags |
-
|
Copyright 2024 - Spreaker Inc. an iHeartMedia Company